
Anti-Müllerian hormone (AMH) is a blood-test marker of how many eggs are left in your ovaries — your ovarian reserve. It estimates egg quantity, not egg quality, and current guidelines say it should not be used on its own to predict your chances of conceiving naturally.
If you have just had your AMH tested, or you are weighing whether to ask for the test, the result can feel like a number with too much power. We want to give it back its right size. This guide walks through what AMH actually measures, what the numbers mean at each age, what is now known about the limits of AMH as a fertility test, and how to interpret a result you weren't expecting — without losing perspective on everything else that matters.
- AMH is produced by small developing follicles in the ovaries and reflects ovarian reserve — your remaining egg supply.3
- AMH levels peak in the mid-twenties and decline steadily with age, becoming undetectable around menopause.3,4
- AMH does not measure egg quality and does not predict your monthly chance of conceiving naturally, particularly in women with no history of infertility.1,2,5
- The 2025 Fertility and Sterility editorial position is clear: AMH should not be used to predict women's fecundity.5
- Hormonal contraceptives can lower measured AMH significantly, with combined oral pills and the vaginal ring producing the largest effects — values typically rebound after stopping.6
- A low AMH is not a verdict. It is one data point that becomes meaningful only alongside your age, cycle pattern, and how long you have been trying.
What is AMH and what does it actually measure?
Think of AMH as a quiet signal from your ovaries. It is a glycoprotein hormone produced by the granulosa cells surrounding small, growing follicles in your ovaries. Because each remaining follicle contributes a tiny amount of AMH, a blood measurement gives an approximate count of how many follicles are currently in the growing pool — and by extension, an estimate of your overall ovarian reserve.3
That distinction matters. AMH is a quantity signal. It tells you roughly how many eggs you have left in the pipeline. It does not tell you how genetically normal those eggs are, how well they will fertilise, or how likely they are to produce a healthy pregnancy. Those are questions about quality, and AMH cannot answer them.3
Unlike FSH or oestradiol, AMH stays relatively stable across your menstrual cycle, which is why you can have it measured on any day. That convenience is part of why you will find it is the most commonly ordered ovarian reserve test in fertility clinics worldwide.3
What are normal AMH levels by age?
AMH peaks in the mid-twenties and then declines roughly linearly with age. By the late thirties most women are below 1.5 ng/mL, and by the early forties the typical value sits closer to 0.5-1.0 ng/mL.3,4 This age-related fall mirrors the steady depletion of the primordial follicle pool that started before you were born.3
There is no single internationally agreed cut-off for "low," "normal" or "high" AMH, because reference ranges vary by laboratory assay, ethnicity, and clinical context. The figures below show typical average ranges reported in the published literature and used by major fertility clinics — they are a guide, not a verdict.3,4
| Age range | Typical average AMH (ng/mL) | Clinical context |
|---|---|---|
| Under 25 | 3.5-4.5 | Peak ovarian reserve |
| 25-29 | 2.5-3.5 | High reserve |
| 30-34 | 1.5-2.5 | Normal range for age |
| 35-39 | 1.0-1.5 | Reserve declining; still typical for age |
| 40-44 | 0.5-1.0 | Significantly reduced reserve |
| 45+ | <0.5 | Reserve approaching menopause |
A few notes on reading the table. First, individual variation within each age band is large — two healthy 35-year-olds can easily have AMH values of 0.8 and 2.8 ng/mL and both be conceiving normally. Second, an AMH "for your age" matters more than an AMH against a universal benchmark — a 1.0 ng/mL at age 40 looks different from a 1.0 ng/mL at age 30. Third, no single AMH value defines infertility on its own.1,3
Does a low AMH mean I cannot get pregnant naturally?
No — and if you take one thing from this article, take this. The largest and best-designed study to date directly testing this question is Steiner and colleagues' 2017 JAMA paper, which followed 981 women aged 30-44 without a history of infertility who had been trying to conceive for three months or less. Women with biomarkers of diminished ovarian reserve (low AMH or high FSH) were no less likely to conceive within six or twelve cycles than women with normal markers.1
You will find the same finding in a different group of women. A 2024 study in Archives of Gynecology and Obstetrics reported that ovarian reserve markers (including AMH) did not differ between women with unexplained infertility and women whose partners had male-factor issues, and a low AMH did not influence the chance of natural conception.2
In 2025, the journal Fertility and Sterility published an editorial with a title that leaves little room for doubt: "Do not measure antimüllerian hormone to predict women's fecundity." Its conclusion speaks directly to you: AMH levels do not influence time to spontaneous conception, and using AMH this way leads to inappropriate counselling.5
If you want it in clinical language, the 2020 ASRM Committee Opinion on ovarian reserve testing puts it this way: ovarian reserve tests are "good predictors of oocyte yield" in IVF "but poor independent predictors of reproductive potential, and therefore should not be used as a fertility test or to deny access to infertility treatment".4
Why does AMH measure quantity but not quality?
Here is the distinction that matters most for you. AMH is produced by the follicles in your ovaries that have already started growing. The more growing follicles you have, the more AMH appears in your blood. So AMH counts what is in your follicle pool, but it does not measure what is inside each of your eggs — its chromosomal integrity, its mitochondrial energy, its developmental competence.3
Egg quality declines with age for separate reasons, mostly related to the gradual accumulation of meiotic errors and the slow loss of mitochondrial function inside each oocyte. A 2014 analysis of 15,169 trophectoderm biopsies showed that aneuploidy rates follow a U-shaped pattern with maternal age — they are lowest in the late twenties (roughly one in four embryos affected) and climb steeply from there, reaching around 40% at age 35, around 60% at age 40, and over 80% by age 43.7
That separation matters for you. AMH and aneuploidy both decline with age, but they do so through different biology. You can be in your late thirties with an AMH of 0.7 ng/mL and still produce a chromosomally normal egg that becomes a healthy pregnancy — because the question of whether you ovulate a euploid egg this cycle does not depend on the size of your remaining follicle pool.1,5,7
What does an AMH test actually tell you?
It depends on where you are in your fertility journey. In a fertility clinic setting, AMH is genuinely useful for two specific decisions: planning the dose of ovarian-stimulation medication for IVF, and counselling about likely response (poor, normal, or hyper-responder).3,4 Outside the IVF setting it has narrower applications.4,5
A 2014 review in Human Reproduction Update confirmed what you may want to know: both AMH and antral follicle count (AFC) reliably predict ovarian response to stimulation but do not, by themselves, predict whether a pregnancy will result.3 If you are deciding whether to consider egg freezing or beginning IVF, your AMH adds useful information. If you are trying naturally and otherwise healthy, your AMH is more often a source of anxiety than a clinically actionable number.4,5
There are a handful of specific situations where AMH is genuinely informative for non-IVF decisions: investigating premature ovarian insufficiency (very low AMH alongside elevated FSH and missed periods), supporting a PCOS diagnosis where ultrasound is unclear (elevated AMH), and predicting menopausal timing in research contexts (still imprecise at the individual level).4,8
How does AMH appear in PCOS?
If you have polycystic ovary syndrome, your AMH tends to be elevated — sometimes two to three times the typical age-band value — because you carry an unusually large pool of small antral follicles, and each follicle contributes AMH.8 The 2023 International Evidence-Based Guideline for PCOS now lists elevated AMH as an acceptable alternative to ultrasound for confirming polycystic ovarian morphology, one of the three Rotterdam criteria. The guideline explicitly declined to recommend a universal cut-off because different commercial assays produce different absolute values; separate validation studies on widely used assays such as the Roche Elecsys have proposed practical thresholds in the region of 3.2 ng/mL. Either way, your AMH on its own is not sufficient — it must be combined with at least one of the other Rotterdam criteria.8
Here is where many people get confused, so let us be plain with you: a high AMH in the context of PCOS is not a sign of better fertility. PCOS often involves ovulatory dysfunction, insulin resistance, and an inflammatory environment that can complicate conception, even though your egg pool itself is large.8 If you have PCOS and an elevated AMH, your number reflects the size of your antral follicle pool — it does not mean you are more fertile than someone with a "normal" AMH.
What can artificially raise or lower an AMH measurement?
Before you read too much into a single number, it helps to know what can move it. Several things can shift your AMH reading independent of your true ovarian reserve, and they matter when you are interpreting your own result.
Hormonal contraception is the largest of these, and if you use it, you should know what it does to your number. In a 2023 population study of 42,684 women published in Fertility and Sterility, current users of combined oral contraceptives, the vaginal ring, the contraceptive implant, and hormonal IUDs all had significantly lower mean AMH values than non-users — with combined pills and the ring producing the largest measured reductions. The effect was strongest in long-term users, and AMH values typically rebound toward baseline once you stop hormonal contraception.6 If you have just come off the pill and tested AMH within a few months, your number is almost certainly an undercount of your true reserve.
Other influences include: time of measurement (AMH is more stable than other reproductive hormones but can still vary modestly across the cycle), recent ovarian surgery (which can lower AMH by removing follicle-containing tissue), and laboratory assay differences (different commercial AMH assays give different absolute values).3,4
Comparing the main ovarian reserve tests
If your clinic has mentioned more than one ovarian reserve test, here is how they fit together for you. Three tests are commonly used together or interchangeably to assess your ovarian reserve, and you may see any combination of them on your results. They measure related things, but they are not equivalent.
| Test | What it measures | Best for | Limitations |
|---|---|---|---|
| AMH (blood) | Output from growing follicles; estimates total follicle pool | Stable across the cycle; predicts IVF response; supports PCOS diagnosis | Does not measure egg quality; suppressed by hormonal contraception; assay variation |
| FSH (blood, day 2-4) | Pituitary effort to recruit a follicle | Detecting overt ovarian decline | Varies cycle to cycle; less sensitive in early decline; cycle-dependent |
| AFC (transvaginal ultrasound) | Direct count of small follicles visible on scan | Real-time visual; complements AMH | Operator-dependent; cycle-day sensitive; requires equipment |
The 2020 ASRM committee opinion is clear: you and your clinician should interpret any single test in the context of your full clinical picture — your age, your prior pregnancy history, your cycle regularity, and how long you have been trying.4
What should I do if my AMH came back low?
A low AMH result is one of the more frightening numbers in fertility testing — and most of the fear comes from how it is communicated rather than what it actually means. Here is a calmer framework.
First, give the number context. If you are under 35, have regular cycles, and have been trying for less than six months, a low AMH on its own is not a reason to change your plan.1,4,5 If you are 35 or older with irregular cycles or more than six months of trying without success, it is information that may justify a fertility evaluation. For more on the conversation about age, AMH, and natural conception, see our guide on trying to conceive at 35+.10
Second, separate quantity from quality. A low AMH tells you the pool is smaller. It does not tell you that this month's ovulated egg is abnormal.3,7
Third, think about what you can support. The egg quality literature suggests that some lifestyle and nutritional factors are associated with better reproductive outcomes regardless of ovarian reserve status — covered in depth in our review of the top fertility supplements and in our practical guide to fertility supplements for women over 35. CoQ10 supplementation has been studied specifically in women with diminished ovarian reserve undergoing IVF; a 2024 meta-analysis of six randomised trials (n=1,529) found that pretreatment with 200-600 mg per day was associated with more retrieved oocytes, higher clinical pregnancy rates, and reduced cycle cancellations.11 Vitamin D sufficiency is associated with better assisted reproduction outcomes in a 2018 meta-analysis of 11 cohort studies (n=2,700; OR 1.33, 95% CI 1.08-1.65 for live birth in replete vs deficient women).12 Omega-3 supplement use was associated with a fecundability ratio of 1.51 (95% CI 1.12-2.04) in a 2022 prospective cohort study of 900 women aged 30-44.9
For broader lifestyle and nutritional context that applies to anyone working on how to improve egg quality naturally, our pillar article covers the full evidence base, including sleep, diet pattern, oxidative stress, and the mitochondrial mechanism behind age-related egg quality changes.
A practical note on the supplements above: it is worth discussing any new supplement with your GP or fertility specialist before starting, particularly if you are taking anticoagulants (CoQ10 and high-dose omega-3 can both affect bleeding parameters), already supplementing vitamin D from another source, or pregnant. Doses, brands, and form (for example ubiquinol vs ubiquinone, or D3 vs D2) can also be worth a brief conversation rather than guesswork.
Fourth, talk to a specialist if you are 35 or older or have been trying for over a year (over six months if 35+). NICE guideline NG257 (March 2026) recommends earlier referral for women aged 36 and over.10
How does AMH change after fertility treatments and surgery?
If you have had procedures that remove or affect ovarian tissue, expect your measured AMH to be lower afterwards. Endometrioma surgery (particularly cystectomy), ovarian drilling for PCOS, and any surgery requiring removal of part of an ovary can reduce your AMH proportionally to the tissue affected.4 If you have undergone chemotherapy or pelvic radiation, those treatments can also reduce your AMH significantly, with the size of the effect depending on the regimen and your reserve beforehand.4
Here's some reassurance: a single elevated FSH or low AMH measurement after such a procedure does not necessarily mean menopause is near, even though it does indicate that follicle numbers are now lower than they were before. If you are considering fertility-preserving options (such as egg freezing) before treatment, AMH testing alongside an antral follicle count is a reasonable input to that conversation.3,4
Frequently Asked Questions
Can I improve my AMH levels?
There is no reliable evidence that any supplement, diet, or lifestyle change meaningfully raises AMH, because AMH reflects the size of your remaining follicle pool, which is set largely by age and genetics.3,4 What you can support is the developmental environment of the follicles that are currently growing — through nutritional adequacy (folate, vitamin D, omega-3), antioxidant status (CoQ10 has the most evidence in women with diminished ovarian reserve), and broader lifestyle factors covered in our egg quality guide.9,11,12
What is the lowest AMH that can still result in pregnancy?
There is no recognised lower limit. Spontaneous pregnancies have been documented at AMH values below 0.1 ng/mL, including in women later confirmed to have premature ovarian insufficiency. The Steiner 2017 JAMA cohort included women with very low AMH values, and they were not less likely to conceive within 12 cycles than women with normal reserve.1,5
Should I get my AMH tested if I am trying to conceive?
If you are under 35, have regular periods, and have been trying for less than six months, current evidence does not support routine AMH testing for natural conception planning.4,5 If you are over 35, have irregular cycles, have a personal or family history of early menopause, or have been trying for more than a year (over six months if 35+), AMH alongside other tests becomes more informative as part of a broader fertility evaluation.10
Does birth control affect my AMH result?
Yes. Current hormonal contraceptive use is associated with measurably lower AMH values, with combined oral pills and the vaginal ring producing the largest reductions in the 2023 population study of 42,684 women.6 Values typically rebound toward your true baseline after stopping. If you have just come off hormonal birth control and tested AMH within the first few months, your number probably underestimates your reserve.
Is high AMH always good?
No. A very high AMH is most often associated with polycystic ovary syndrome, which is itself a leading cause of anovulation and subfertility.8 If your AMH is elevated and you have PCOS, your number reflects a large pool of small antral follicles, not a fertility advantage. The 2023 international PCOS guideline accepts elevated AMH as an alternative to ultrasound for confirming polycystic ovarian morphology, but only alongside another Rotterdam criterion.8
What is the difference between AMH and FSH?
AMH is produced by your growing follicles and reflects the supply side — how many follicles you have. FSH is produced by your pituitary and reflects the demand side — how hard your brain is working to recruit a follicle. As your reserve declines, your AMH falls and your FSH rises. Your AMH is more stable across your cycle; your FSH varies day to day and is typically measured early in your cycle (day 2-4).3,4
Can AMH predict when I will go through menopause?
In research populations, AMH correlates with age at menopause — but at your individual level, prediction is imprecise. The 2020 ASRM committee opinion notes that AMH is a useful research tool for menopausal timing but is not accurate enough for you to base your individual planning on a single value.4
Supporting Your Fertility with FertilitySmart
Whatever your AMH result is telling you, the practical question is how to support the eggs you have. Nutrients such as CoQ10, folate, vitamin D, and omega-3 fatty acids play documented roles in your oocyte and overall reproductive health, and the evidence is strongest if you have diminished ovarian reserve.9,11,12
At FertilitySmart, we offer you both fertility supplements for women and fertility supplements for men formulated with CoQ10, folic acid, vitamin D, vitamin E, zinc, and other evidence-supported nutrients discussed in this guide. Explore our range and choose the formula that fits where you are on your fertility journey.
Related Reading
If you found this guide useful, these articles explore the connected topics in more depth.
- How to Improve Egg Quality Naturally
The pillar guide for this cluster. Covers the mitochondrial, antioxidant, and lifestyle evidence behind oocyte quality across the lifespan. - What Does CoQ10 Do for Fertility?
The mechanism, dosing, and IVF trial evidence behind CoQ10's role in egg quality and diminished ovarian reserve. - Vitamin E for Fertility
Antioxidant evidence relevant to follicular health and oxidative stress. - Fertility Supplements for Women Over 35
What the evidence supports for women approaching the steeper portion of age-related fertility decline. - Trying to Conceive at 35+
A realistic guide to the conversation about age, AMH, and natural conception. - Top 10 Fertility Supplements
A ranking of the most evidence-supported nutrients for fertility, with study summaries. - PCOS and Fertility
The pillar guide to PCOS, where elevated AMH is part of the diagnostic picture. - Fertility Diet
The dietary patterns most consistently associated with better fertility outcomes. - Sleep and Fertility
How sleep quality and circadian rhythm affect reproductive hormones. - Causes of Infertility in Women
A broader look at the most common medical causes of female infertility, with hopeful framing.
References
- Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318(14):1367-1376. doi.org/10.1001/jama.2017.14588
- Galati G, Reschini M, Chinè A, Benaglia L, Viganò P, Somigliana E, Vercellini P, Muzii L. Ovarian reserve does not influence natural conception: insights from infertile women. Archives of Gynecology and Obstetrics. 2024;310(5):2691-2696. doi.org/10.1007/s00404-024-07741-6
- La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update. 2014;20(1):124-140. doi.org/10.1093/humupd/dmt037
- Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility. 2020;114(6):1151-1157. doi.org/10.1016/j.fertnstert.2020.09.134
- de Ziegler D, Sean S, Pirtea P. Do not measure antimüllerian hormone to predict women's fecundity. Fertility and Sterility. 2025. Published online 22 July 2025. doi.org/10.1016/j.fertnstert.2025.07.025
- Nelson SM, Ewing BJ, Gromski PS, Briggs SF. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women. Fertility and Sterility. 2023;119(6):1069-1077. doi.org/10.1016/j.fertnstert.2023.02.019
- Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertility and Sterility. 2014;101(3):656-663.e1. doi.org/10.1016/j.fertnstert.2013.11.004
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2023;108(10):2447-2469. doi.org/10.1210/clinem/dgad463
- Stanhiser J, Jukic AMZ, McConnaughey DR, Steiner AZ. Omega-3 fatty acid supplementation and fecundability. Human Reproduction. 2022;37(5):1037-1046. doi.org/10.1093/humrep/deac027
- National Institute for Health and Care Excellence (NICE). Fertility problems: assessment and treatment (NG257). London: NICE; March 2026.
- Lin G, Li X, Yie SLJ, Xu L. Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis. Annals of Medicine. 2024;56(1):2389469. doi.org/10.1080/07853890.2024.2389469
- Chu J, Gallos I, Tobias A, Tan B, Eapen A, Coomarasamy A. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Human Reproduction. 2018;33(1):65-80. doi.org/10.1093/humrep/dex326
Marina Carter
Health & Fertility Writer at FertilitySmart
Marina Carter is FertilitySmart's lead writer on fertility, preconception health, and reproductive nutrition. She translates the clinical and nutritional evidence base into honest, practical guidance for individuals and couples trying to conceive, working closely with the product team to ensure every article reflects current peer-reviewed research and the lived emotional reality of the fertility journey. Read Full Bio →